ProKidney Corp’s recently made public that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported $0.63 million on Apr 10 ’25. In the deal valued at $0.61 per share,1,032,218 shares were bought. As a result of this transaction, Control Empresarial de Capital now holds 72,592,325 shares worth roughly $53.72 million.
Then, Control Empresarial de Capital bought 1,900 shares, generating $1,155 in total proceeds. Upon buying the shares at $0.61, the Add’l Rep. Persons-see Ex.99-1 now owns 72,594,225 shares.
Before that, Weber Darin J. sold 16,412 shares. ProKidney Corp shares valued at $41,030 were divested by the Chief Regulatory Officer at a price of $2.50 per share. As a result of the transaction, Weber Darin J. now holds 103,480 shares, worth roughly $76575.2.
JP Morgan initiated its ProKidney Corp [PROK] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. BofA Securities revised its rating on January 02, 2024. It rated PROK as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PROK
On Monday, ProKidney Corp [NASDAQ:PROK] saw its stock jump 1.19% to $0.74. Over the last five days, the stock has gained 24.98%. ProKidney Corp shares have fallen nearly -56.21% since the year began. Nevertheless, the stocks have fallen -54.88% over the past one year. While a 52-week high of $4.44 was reached on 01/06/25, a 52-week low of $0.46 was recorded on 04/09/25. SMA at 50 days reached $1.1267, while 200 days put it at $1.7775.
Levels Of Support And Resistance For PROK Stock
The 24-hour chart illustrates a support level at 0.6837, which if violated will result in even more drops to 0.6273. On the upside, there is a resistance level at 0.8127. A further resistance level may holdings at 0.8853. The Relative Strength Index (RSI) on the 14-day chart is 40.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0493, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.03%. Stochastics %K at 40.24% indicates the stock is a holding.
How much short interest is there in ProKidney Corp?
A steep rise in short interest was recorded in ProKidney Corp stocks on 2025-03-31, dropping by 5924.0 shares to a total of 11.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 11.93 million shares. There was a decline of -0.05%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 25, 2023 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $16 price target.
